| 1 |
32245905 | Phosphoproteomic Identification of Vasopressin/cAMP/Protein Kinase A-Dependent Signaling in Kidney. | 2021 May |
1 |
| 2 |
33904139 | Efficacy of oral tolvaptan for severe edema and hyponatremia in a patient with refractory nephrotic syndrome. | 2021 Nov |
1 |
| 3 |
34884753 | Updates and Perspectives on Aquaporin-2 and Water Balance Disorders. | 2021 Nov 30 |
1 |
| 4 |
31616061 | Targeting the vasopressin type-2 receptor for renal cell carcinoma therapy. | 2020 Feb |
1 |
| 5 |
32486031 | The Vasopressin Receptor 2 Mutant R137L Linked to the Nephrogenic Syndrome of Inappropriate Antidiuresis (NSIAD) Signals through an Alternative Pathway that Increases AQP2 Membrane Targeting Independently of S256 Phosphorylation. | 2020 May 29 |
2 |
| 6 |
32683063 | Pharmacological Dilutional Therapy Using the Vasopressin Antagonist Tolvaptan for Young Patients With Cystinuria: A Pilot Investigation. | 2020 Oct |
1 |
| 7 |
32903920 | Identification of a Novel Arginine Vasopressin Receptor 2 Mutation (p.V183M) in a Chinese Family with Nephrogenic Diabetes Insipidus. | 2020 Jul |
2 |
| 8 |
32996499 | The impact of metal coordination on the assembly of bis(indolyl)methane-naphthalene-diimide amphiphiles. | 2020 Oct 12 |
1 |
| 9 |
30242840 | NHA2 promotes cyst development in an in vitro model of polycystic kidney disease. | 2019 Jan |
1 |
| 10 |
31189221 | New insights into the transcriptional regulation of aquaporin-2 and the treatment of X-linked hereditary nephrogenic diabetes insipidus. | 2019 Jun 30 |
2 |
| 11 |
31588538 | Nephrogenic Diabetes Insipidus. | 2019 |
2 |
| 12 |
28913879 | Short T2 imaging using a 3D double adiabatic inversion recovery prepared ultrashort echo time cones (3D DIR-UTE-Cones) sequence. | 2018 May |
2 |
| 13 |
29311539 | Tolvaptan for Fluid Management in Living Donor Liver Transplant Recipients. | 2018 Jan 9 |
1 |
| 14 |
29478202 | Activation of AQP2 water channels without vasopressin: therapeutic strategies for congenital nephrogenic diabetes insipidus. | 2018 Jun |
1 |
| 15 |
29499256 | Resolution of Diabetes Insipidus After Pyeloplasty: A Case Report and Review of the Literature. | 2018 May |
1 |
| 16 |
29650969 | AKAPs-PKA disruptors increase AQP2 activity independently of vasopressin in a model of nephrogenic diabetes insipidus. | 2018 Apr 12 |
1 |
| 17 |
29901649 | Nephrogenic diabetes insipidus in initial stage of acute lymphoblastic leukemia and relapse after haploidentical hematopoietic stem-cell transplantation: A case report. | 2018 Jun |
1 |
| 18 |
29991464 | A Novel Mutation in the AVPR2 Gene Causing Congenital Nephrogenic Diabetes Insipidus | 2018 Nov 29 |
1 |
| 19 |
27990576 | Coordinated shift of olfactory amino acid responses and V2R expression to an amphibian water nose during metamorphosis. | 2017 May |
1 |
| 20 |
28134709 | Nephrogenic diabetes insipidus. | 2017 Apr |
7 |
| 21 |
28194573 | Hyponatremia and cyst growth in neonatal polycystic kidney disease: a case for aquaretics? | 2017 May |
2 |
| 22 |
27734039 | Structure and dynamics of water molecules confined in triglyceride oils. | 2016 Oct 26 |
1 |
| 23 |
28124939 | [Current options of treatment of hyponatremia]. | 2016 Winter |
1 |
| 24 |
25594563 | A novel therapeutic effect of statins on nephrogenic diabetes insipidus. | 2015 Feb |
1 |
| 25 |
25734677 | [Syndrome of inadequate ADH secretion: pitfalls in diagnosis and therapy]. | 2015 Mar |
1 |
| 26 |
25926290 | Urine osmolarity predicts the body weight-reduction response to tolvaptan in chronic kidney disease patients: a retrospective, observational study. | 2015 |
1 |
| 27 |
26240594 | A Minireview on Vasopressin-regulated Aquaporin-2 in Kidney Collecting Duct Cells. | 2015 Jun |
2 |
| 28 |
26516441 | Impact of hyponatremia on frequency of complications in patients with decompensated liver cirrhosis. | 2015 Oct |
1 |
| 29 |
23736674 | Urinary concentration: different ways to open and close the tap. | 2014 Aug |
1 |
| 30 |
23950570 | Novel AQP2 mutation causing congenital nephrogenic diabetes insipidus: challenges in management during infancy. | 2014 Jan |
1 |
| 31 |
24485635 | Infiltrated atrial fat characterizes underlying atrial fibrillation substrate in patients at risk as defined by the ARIC atrial fibrillation risk score. | 2014 Mar 1 |
1 |
| 32 |
24620844 | Number of P-wave fragmentations on P-SAECG correlates with infiltrated atrial fat. | 2014 Mar |
1 |
| 33 |
24944242 | Characterization of the effects of the vasopressin V2 receptor on sweating, fluid balance, and performance during exercise. | 2014 Aug 15 |
1 |
| 34 |
25179972 | Case report: new treatment with Tolvaptan for heart failure after cardiac surgery. | 2014 Aug |
1 |
| 35 |
25211589 | Diabetes insipidus: celebrating a century of vasopressin therapy. | 2014 Dec |
1 |
| 36 |
26278096 | Water Dynamics in Metal-Organic Frameworks: Effects of Heterogeneous Confinement Predicted by Computational Spectroscopy. | 2014 Aug 21 |
1 |
| 37 |
30534332 | Efficacy of tolvaptan in a patient with right-sided heart failure and renal dysfunction refractory to diuretic therapy. | 2014 Jun |
1 |
| 38 |
23364801 | Inherited secondary nephrogenic diabetes insipidus: concentrating on humans. | 2013 Apr 15 |
1 |
| 39 |
23609837 | Nephrogenic diabetes insipidus secondary to syphilis infection. | 2013 Jul |
1 |
| 40 |
23935101 | Noncanonical control of vasopressin receptor type 2 signaling by retromer and arrestin. | 2013 Sep 27 |
1 |
| 41 |
21834801 | Lack of responsiveness to 1-desamino-D arginin vasopressin (desmopressin) in male patients with nephrogenic syndrome of inappropriate antidiuresis: from bench to bedside. | 2012 Mar |
1 |
| 42 |
22027579 | Tolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosis. | 2012 Mar |
1 |
| 43 |
22052024 | AVPR2 gene and weight changes during triathlons. | 2012 Jan |
2 |
| 44 |
22154540 | A family with hyponatremia and the nephrogenic syndrome of inappropriate antidiuresis. | 2012 Apr |
1 |
| 45 |
22325688 | Persistent elevation of urine aquaporin-2 during water loading in a child with nephrogenic syndrome of inappropriate antidiuresis (NSIAD) caused by a R137L mutation in the V2 vasopressin receptor. | 2012 Feb 10 |
2 |
| 46 |
22427315 | Congenital nephrogenic diabetes insipidus: the current state of affairs. | 2012 Dec |
4 |
| 47 |
22470853 | Vasopressin receptor antagonists and their role in clinical medicine. | 2012 Mar |
1 |
| 48 |
22474537 | Membrane protein stability analyses by means of protein energy profiles in case of nephrogenic diabetes insipidus. | 2012 |
1 |
| 49 |
22722264 | Long-term treatment of hyponatremic patients with nephrogenic syndrome of inappropriate antidiuresis: personal experience and review of published case reports. | 2012 |
2 |
| 50 |
26069764 | Aquaporin-2: new mutations responsible for autosomal-recessive nephrogenic diabetes insipidus-update and epidemiology. | 2012 Jun |
3 |